Agilent Technologies appoints Dr. Tachi Yamada to board of directors
Agilent Technologies Inc. (NYSE:A) today announced the appointment of Dr. Tachi Yamada to its board of directors. Dr. Yamada currently serves as president of the Global Health Program of the Bill & Melinda Gates Foundation, a position he has held since June 2006.
- (1888PressRelease) January 18, 2011 - Prior to joining the Gates Foundation, Dr. Yamada was chairman of research and development for GlaxoSmithKline Inc., and previously held research and development positions at SmithKline Beecham. Dr. Yamada also served as chairman of the department of internal medicine at the University of Michigan Medical School and Physician-in-Chief of the University of Michigan Medical Center.
Bill Sullivan, Agilent president and CEO said, "With his experience as the president of the Global Health Program of the Bill & Melinda Gates Foundation, as well as his significant research and development background, Dr. Yamada adds a new dimension to our Board. In addition, his extensive pharmaceutical industry knowledge coupled with his medical background gives him a unique insight into a number of issues facing Agilent that will serve us well as we continue to grow our life sciences business. I am pleased to welcome Dr. Yamada to our Board and look forward to working with him."
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is the world's premier measurement company and a technology leader in chemical analysis, life sciences, electronics and communications. The company's 18,500 employees serve customers in more than 100 countries. Agilent had net revenues of $5.4 billion in fiscal 2010. Information about Agilent is available at www.agilent.com
NOTE TO EDITORS: Further technology, corporate citizenship and executive news is available at www.agilent.com/go/news
Agilent Technologies Inc.
Amy Flores, + 408-345-8194
amy_flores ( @ ) agilent dot com
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam